Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Madeleine D. Burns, Brittany P. Boribong, Yannic C. Bartsch, Maggie Loiselle, Kerri J. St. Denis, Maegan L. Sheehan, Jessica W. Chen, Jameson P. Davis, Rosiane Lima, Andrea G. Edlow, Alessio Fasano, Alejandro B. Balazs, Galit Alter, Lael M. Yonker
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2022-03-01
Schriftenreihe:Vaccines
Schlagworte:
SARS-CoV-2
COVID-19
pediatrics
adolescents
vaccines
boosters
Online Zugang:https://www.mdpi.com/2076-393X/10/4/492
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge